PuSH - Publikationsserver des Helmholtz Zentrums München

Weber, S. ; Salabei, J.K.* ; Möller, G. ; Kremmer, E. ; Bhatnagar, A.* ; Adamski, J. ; Barski, O.A.*

Aldo-Keto Reductase 1B15 (AKR1B15): A mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates.

J. Biol. Chem. 290, 6531-6545 (2015)
Verlagsversion DOI PMC
Open Access Gold
Alto-keto reductases (AKRs) comprise a superfamily of proteins involved in the reduction and oxidation of biogenic and xenobiotic carbonyls. In humans, at least 15 AKR superfamily members have been identified so far. One of these is a newly identified gene locus, AKR1B15, which clusters on chromosome 7 with the other human AKR1B subfamily members (i.e. AKR1B1 and AKR1B10). We show that alternative splicing of the AKR1B15 gene transcript gives rise to two protein isoforms with different N termini: AKR1B15.1 is a 316-amino acid protein with 91% amino acid identity to AKR1B10; AKR1B15.2 has a prolonged N terminus and consists of 344 amino acid residues. The two gene products differ in their expression level, subcellular localization, and activity. In contrast with other AKR enzymes, which are mostly cytosolic, AKR1B15.1 co-localizes with the mitochondria. Kinetic studies show that AKR1B15.1 is predominantly a reductive enzyme that catalyzes the reduction of androgens and estrogens with high positional selectivity (17β-hydroxysteroid dehydrogenase activity) as well as 3-ketoacyl-CoA conjugates and exhibits strong cofactor selectivity toward NADP(H). In accordance with its substrate spectrum, the enzyme is expressed at the highest levels in steroid-sensitive tissues, namely placenta, testis, and adipose tissue. Placental and adipose expression could be reproduced in the BeWo and SGBS cell lines, respectively. In contrast, AKR1B15.2 localizes to the cytosol and displays no enzymatic activity with the substrates tested. Collectively, these results demonstrate the existence of a novel catalytically active AKR, which is associated with mitochondria and expressed mainly in steroid-sensitive tissues.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.573
1.208
14
16
Tags
GAC
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter 3-keto-acyl-CoA; Aldo-Keto Reductase; alternative splicing; enzyme kinetics; gene expression; mitochondria; oxidation-reduction (redox); reductase; steroid; Chain L-3-hydroxyacyl-coa Dehydrogenase; Gamma-hydroxybutyrate; Delta(4)-3-oxosteroid 5-beta-reductase; 3-hydroxyacyl-coa Dehydrogenase; Subcellular-localization; Diabetic Complications; Aldehyde Reductase; Potassium Channels; Insulin-secretion; Active-site
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 0021-9258
e-ISSN 1083-351X
Quellenangaben Band: 290, Heft: 10, Seiten: 6531-6545 Artikelnummer: , Supplement: ,
Verlag American Society for Biochemistry and Molecular Biology
Verlagsort Bethesda
Begutachtungsstatus Peer reviewed
Institut(e) Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Molecular Immunology (IMI)
Institute of Experimental Genetics (IEG)
POF Topic(s) 30201 - Metabolic Health
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
90000 - German Center for Diabetes Research
Forschungsfeld(er) Genetics and Epidemiology
Immune Response and Infection
PSP-Element(e) G-505600-001
G-501793-001
G-501900-061
Scopus ID 84925002765
PubMed ID 25577493
Erfassungsdatum 2015-03-26